🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT07345429
Active, not recruiting Observational

One-Year Outcomes After Conversion Bariatric Surgery

NCT07345429 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-11-12
Last updated
2026-02-03

Condition(s) studied

Obesity & OverweightBariatric SurgeryRevisional Bariatric Surgery

Study summary

Obesity is a growing global public health problem, and bariatric surgery is currently the most effective treatment for achieving sustained weight loss and improving obesity-related comorbidities. However, a subset of patients experience inadequate weight loss or weight regain following primary bariatric surgery, which may lead to the recurrence of metabolic complications and reduced quality of life. In such cases, conversion bariatric surgery, defined as the surgical conversion from one bariatric procedure to another, is considered an important therapeutic option. Despite the increasing number of conversion procedures, comprehensive longitudinal data evaluating anthropometric, biochemical, and nutritional outcomes after conversion bariatric surgery remain limited.

This study aims to prospectively evaluate individuals undergoing conversion bariatric surgery due to weight regain following primary bariatric surgery. Anthropometric measurements, biochemical parameters, and nutritional status will be assessed preoperatively and at 1 year after surgery. By evaluating weight loss outcomes together with metabolic and nutritional changes, this study seeks to provide clinically relevant evidence to guide postoperative follow-up strategies, optimize nutritional management, and support multidisciplinary care in patients undergoing conversion bariatric surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18-45 years * Previously underwent bariatric surgery * Subsequently underwent conversion bariatric surgery due to suboptimal clinical response Suboptimal clinical response defined as either: * Suboptimal Clinical Response (SCR): maximum total weight loss (TWL%) of \<20% within 18 months after metabolic and bariatric surgery * Recurrent Weight Gain (RWG): regaining \>30% of initial postoperative weight loss after achieving initial weight reduction Exclusion Criteria: * Pregnancy or lactation * Presence of acute illness or infection * Comorbid conditions that could limit treatment efficacy or compromise safety * Participation in professional athletic activity

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Mudanya Univesity Osmangazi Bursa

More Medipol University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07345429 on ClinicalTrials.gov ↗ ← All trials in Turkey